Holen Sie sich die Stockscreener-App
36.27
0.55%
0.20
Schlusskurs vom Vortag:
$36.07
Offen:
$36.42
24-Stunden-Volumen:
49,583
Relative Volume:
0.64
Marktkapitalisierung:
$1.84B
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-27.55M
KGV:
-63.43
EPS:
-0.5718
Netto-Cashflow:
$-41.40M
1W Leistung:
+2.66%
1M Leistung:
-26.70%
6M Leistung:
+64.12%
1J Leistung:
+745.45%
1-Tages-Spanne:
$34.70
$36.78
1-Wochen-Bereich:
$33.51
$38.29
52-Wochen-Spanne:
$4.3075
$57.14
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
36.27 | 1.84B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-06 | Eingeleitet | TD Cowen | Buy |
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
NBTX Stock Price, Quote & Chart - ChartMill
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire Inc.
XP posts downbeat Q1 earnings, joins Akamai Technologies and other big stocks moving lower in Tuesday's pre-market session - MSN
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's P - Benzinga
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer - ChartMill
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpStill a Buy? - MarketBeat
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - ChartMill
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 7.2% HigherShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - ChartMill
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):